Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine
Adamson, L.; Curry, S.H.; Bridges, P.K.; Firestone, A.F.; Lavin, N.I.; Lewis, D.M.; Watson, R.D.; Xavier, C.M.; Anderson, J.A.
Diseases of the Nervous System 34(4): 181-191
1973
ISSN/ISBN: 0012-3714 PMID: 4711886 Document Number: 65986
Document emailed within 1 workday
Related Documents
Chandra, O.; Bernard, J.; Matussek, N. 1974: Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats Arzneimittel-Forschung 24(11): 1821-1824Freeman, H. 1973: A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics Diseases of the Nervous System 34(6): 289-293
Leff, J.P.; Tress, K.H. 1986: The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate International Clinical Psychopharmacology 1(Suppl 1): 27-40
Stevens, B. 1976: The social value of fluphenazine decanoate Acta Psychiatrica Belgica 76(5): 792-804
Small, J.G.; Kellams, J. 1974: Early hospital experience with fluphenazine decanoate Diseases of the Nervous System 35(10): 453-456
Náhunek, K.; Rodová, A.; Svestka, J. 1970: Clinical experience with fluphenazine decanoate in psychoses Activitas Nervosa Superior 12(1): 47-49
Grosser, H.H. 1970: Experience of psychiatric management of schizophrenia with fluphenazine decanoate Diseases of the Nervous System 31(Suppl): 32-36
Drtil, J. 1989: Treatment of patients dependent on tobacco with fluphenazine decanoate Activitas Nervosa Superior 31(2): 116-117
Timm, U.; Pfeifer, S. 1973: Assay and determination of fluphenazine decanoate in oily solution Die Pharmazie 28(11): 793
Sikora, J.; Krulík, R.; Král, J.; Novotný, J. 1978: Chlorpromazine in the blood of schizophrenics Activitas Nervosa Superior 20(4): 278-280
Savelyeva, M.V.; Baldenkov, G.N.; Kaverina, N.V. 1988: Receptor binding potencies of chlorpromazine, trifluoperazine, fluphenazine and their 10-N-substituted analogues Biomedica Biochimica Acta 47(12): 1085-1087
Walker, C.A. 1983: A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients Pharmatherapeutica 3(5): 289-293
Dencker, S.J.; Elgen, K. 1980: Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics Acta Psychiatrica Scandinavica. Supplementum 279: 5-9
Chaudhary, A.K.; Hubbard, J.W.; McKay, G.; Midha, K.K. 1988: Identification of a quaternary ammonium-linked glucuronide of chlorpromazine in the urine of a schizophrenic patient treated with chlorpromazine Drug Metabolism and Disposition: the Biological Fate of Chemicals 16(3): 506-508
Soni, S.D.; Tench, D.; Ashwood, T.J.; Movin, G. 1990: Pharmacokinetics of an oral controlled release formulation of remoxipride: a double-blind, crossover comparison with conventional formulation in chronic schizophrenics Acta Psychiatrica Scandinavica. Supplementum 358: 45-47
Tomiyama, H.; Takara, I.; Tokumine, J.; Sugahara, K. 2004: Sivelestat sodium hydrate was effective for ARDS in a patient suffering from chronic rheumatoid arthritis with acute exacerbation after failing to respond to high dose steroid pulse therapy Masui. Japanese Journal of Anesthesiology 53(9): 1042-1046
Ellerman, L.A. 1987: Open clinical trial with haloperidol decanoate in patients with psychotic disorders Acta Psiquiatrica y Psicologica de America Latina 33(2): 157-162
Chhaparwal, M.; Saraf, M.L. 1998: Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis Indian Journal of Medical Sciences 52(6): 236-238
Guy, W.; Cleary, P.; Switalski, R. 1977: A comparison of drug-trial schizophrenics with their clinical counterparts Psychopharmacology Bulletin 13(3): 44-45
Stoloff, S.; Samuels, S.; Kerney, D.; Brown, C.P. 2006: Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial Medgenmed: Medscape General Medicine 8(1): 86